The FDA assessed the safety and effectiveness of atidarsagene autotemcel dependant on facts from 37 children who gained atidarsagene autotemcel in two one-arm, open-label scientific trials As well as in an expanded accessibility plan.[seven] Young children who obtained procedure with atidarsagene autotemcel had been in comparison with untreated children (pure https://karelj913jkl6.homewikia.com/user